Actively Recruiting
Mifepristone vs Misoprostol
Led by Montefiore Medical Center · Updated on 2025-08-13
94
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Investigator team hypothesizes that in a randomized trial comparing mifepristone-alone or misoprostol-alone for cervical preparation for procedural abortions at 12 to 16 weeks in hospital-based care, the proportion of patients who achieve successful cervical dilation will be different between the study groups.
CONDITIONS
Official Title
Mifepristone vs Misoprostol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- English or Spanish-speaking
- Ability to give informed consent
- Seeking an induced abortion of a singleton pregnancy
- Pregnancy between 12 weeks, 0 days and 16 weeks, 6 days at time of surgery
You will not qualify if you...
- History of more than two prior Cesarean deliveries
- Sonographic evidence of placenta previa
- Sonographic concern for morbidly adherent placenta
- Prior obstetric hemorrhage requiring transfusion
- Obstructive cervical or lower uterine segment fibroid
- Current use of therapeutic anticoagulation
- Cerclage in place
- History of more than one prior cervical excisional procedure
- Body mass index greater than 50 kg/m^2
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Montefiore Medical Center
The Bronx, New York, United States, 10467
Actively Recruiting
Research Team
L
Laura Fletcher, MD, MPH
CONTACT
A
Antoinette Danvers, MD, MSCR, MBA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here